| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H40N8O2 |
| Molecular Weight | 484.6375 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N2CC[C@H](NC3=NC=NC4=CC(=NN34)C(C)(C)C)C2=O)NC(C)(C)C
InChI
InChIKey=CMVHFGNTABZQJU-HCXYKTFWSA-N
InChI=1S/C25H40N8O2/c1-15(34)28-18-12-16(30-25(5,6)7)8-9-19(18)32-11-10-17(22(32)35)29-23-27-14-26-21-13-20(24(2,3)4)31-33(21)23/h13-14,16-19,30H,8-12H2,1-7H3,(H,28,34)(H,26,27,29)/t16-,17+,18-,19+/m1/s1
| Molecular Formula | C25H40N8O2 |
| Molecular Weight | 484.6375 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 6.2 nM [IC50] | |||
| 3.6 nM [IC50] |
